Apomorphininjektionstherapie bei Morbus Parkinson

Forskningsoutput: TidskriftsbidragÖversiktsartikel

Abstract

Apomorphine as subcutaneous injections offers a valuable and effective treatment alternative for Parkinson patients with oral medication-resistant "off' phases. Its efficacy is stable during long-term therapy, with no signs of patient tolerance. Adverse events are usually mild. The best results are obtained with relatively young, active, and cognitively intact patients. Intermittent s.c. apomorphine therapy can improve the patients' possibilities to continue to work and to live a normal social life, by offering increased freedom and self-confidence through a reliable, quick rescue from the disabling medication-resistant off phases.

Detaljer

Författare
Enheter & grupper
Forskningsområden

Ämnesklassifikation (UKÄ) – OBLIGATORISK

  • Neurologi

Nyckelord

Originalspråktyska
Sidor (från-till)S11-S16
TidskriftAktuelle Neurologie
Volym38
Utgåva nummerSuppl. 1
StatusPublished - 2011
PublikationskategoriForskning
Peer review utfördJa